| abstract |
The present invention provides novel compounds of formula (AA1), as well as compounds for use as a drug for the prevention or treatment of a neurodegenerative disorder, more specifically certain neurological disorders, such as disorders collectively known as tauopathies, and disorders characterized by amyloidogenesis of cytotoxic α synuclein. This invention also relates to the use of these new compounds for the manufacture of drugs suitable for the treatment of such neurodegenerative disorders. This invention additionally relates to pharmaceutical compositions, including those containing these new compounds, and methods for producing these new compounds. |